Factors associated with high 24-month persistence with denosumab: results of a real-world, non-interventional study of women with postmenopausal osteoporosis in Germany, Austria, Greece, and Belgium.

In both countries, persistence rates were lower in patients for whom this reason was given than in those for whom this reason was not given; however, the association did not reach statistical significance for either country ( p = 0.100 and p = 0.163, respectively).

also in 111,027 other papers